SEQUA — Sequana Medical NV Cashflow Statement
0.000.00%
Last trade - 00:00- €52.33m
- €86.41m
- €0.11m
Annual cashflow statement for Sequana Medical NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.1 | -23.6 | -30.8 | -32.6 | -44.7 |
| Depreciation | |||||
| Non-Cash Items | 1.28 | 1.11 | 2.39 | 3.78 | 26 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.514 | -1.52 | 0.584 | -0.945 | -2.24 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17 | -23.6 | -27.5 | -29.1 | -20.3 |
| Capital Expenditures | -0.138 | -0.326 | -0.677 | -0.711 | -0.095 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.004 | -0.012 | 0.024 | -0.011 | -0.005 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.142 | -0.338 | -0.653 | -0.721 | -0.1 |
| Financing Cash Flow Items | -0.194 | 0 | -0.315 | -0.929 | -0.162 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 22.6 | 22.4 | 37.3 | 13.5 | 21.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.43 | -1.42 | 9.27 | -16.3 | 1.22 |